Company profile: U-Systems
1.1 - Company Overview
Company description
- Provider of automated breast ultrasound systems and software that deliver automated breast scans to assist radiologists in detecting breast cancer, particularly in women with dense breast tissue.
Products and services
- Automated Breast Ultrasound System: An automated product delivering ultrasound scans of the breast designed to improve breast cancer detection and assist radiologists working with women who have dense breast tissue
- Breast Ultrasound Software: Radiologist-assistive software that assists detection of breast cancer in dense breast tissue by supporting interpretation of automated breast ultrasound scans
- Ultrasound Systems Engineering and Manufacturing: Ultrasound-based capability that designs, develops, fabricates, and markets innovative systems to assist radiologists in detecting breast cancer in women with dense breast tissue
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to U-Systems
Nativis
HQ: United States
Website
- Description: Provider of therapeutic modalities in development for the treatment of serious disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nativis company profile →
Ceptaris
HQ: United States
Website
- Description: Provider of a proprietary gel formulation of mechlorethamine hydrochloride under development for the treatment of early-stage (stages I–IIA) mycosis fungoides, a type of cutaneous T-cell lymphoma (CTCL); if approved, it would be the first topical treatment for this indication.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ceptaris company profile →
Gilupi
HQ: Germany
Website
- Description: Provider of medical devices and diagnostic solutions for in vivo isolation and analysis of rare circulating cells from blood. Offers GILUPI CellCollector for enriching circulating tumor cells, liquid biopsy sampling, immunofluorescence microscopy, NuPLex technology for RNA detection, and next-generation sequencing for genetic analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gilupi company profile →
NovelStem
HQ: United States
Website
- Description: Provider of diagnostic technology and biotech solutions, including NewStem Diagnostic for early detection of anti-cancer drug resistance aiding targeted cancer treatments, NewStem Therapeutics using proprietary HhESCs for drug and gene screenings to identify genes and drugs for genetic and epigenetic disorders, NewStem Cell Growth Media to improve hPSC growth, and Net Force, a publishing franchise on digital crime, espionage, and crypto.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NovelStem company profile →
Enveric Biosciences
HQ: United States
Website
- Description: Provider of patient-first biotechnology solutions developing rigorously tested, novel cannabinoid medicines and mental health drug candidates, including EB-003, a neuroplastogen for severe disorders without inducing hallucinations; EB-002, a synthetic prodrug of psilocin being studied for psychiatric disorders with altered metabolic and pharmacokinetic properties; and Psybrary, an AI-optimized platform and portfolio of new chemical entities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enveric Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for U-Systems
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to U-Systems
2.2 - Growth funds investing in similar companies to U-Systems
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for U-Systems
4.2 - Public trading comparable groups for U-Systems
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →